Back to Results
First PageMeta Content
Clinical research / Center for Drug Evaluation and Research / Bioequivalence / Center for Biologics Evaluation and Research / Abbreviated New Drug Application / Drug development / Biologic / Biostatistics / Dermatologic and Ophthalmic Drugs Advisory Committee / Food and Drug Administration / Pharmaceutical sciences / Pharmacology


Missing Data Issues in Regulatory Clinical Trials Lisa M. LaVange, PhD Office of Biostatistics OTS/CDER/US FDA
Add to Reading List

Document Date: 2015-02-24 20:15:37

Open Document

File Size: 1,39 MB

Share Result on Facebook
UPDATE